{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:26:01Z","timestamp":1794511561398,"version":"4.9.1"},"reference-count":69,"publisher":"American Chemical Society (ACS)","issue":"21","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/na","name":"NovartisNovartis BioMedical Research Inc","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>NLRP3 is a molecular sensor present in innate immune cells which recognizes a variety of danger signals such as MSU, ATP, or A\u03b2. Upon activation, it seeds a protein complex termed the inflammasome, which leads to secretion of the proinflammatory cytokines IL-1\u03b2 and IL-18 and initiates pyroptotic cell death. NLRP3 inflammasome activation has been associated with a wide range of diseases including atherosclerosis, gout, and cancer. In this publication, we describe the replacement of the phenol moiety with indoles in the recently described pyridazine scaffold. This replacement required a shift of the hydrogen bond donor from the \u201cortho\u201d to the \u201cmeta\u201d position, relative to the pyridazine ring. Initial indole analog 7 demonstrated a robust in vivo IL-1\u03b2 inhibition, but also a significant hERG inhibition. Decreasing lipophilicity led to the discovery of NP3-742, demonstrating a favorable overall profile including diminished hERG inhibition and in vivo efficacy in a mouse peritonitis model.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c02412","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:38:35Z","timestamp":1760542715000},"page":"23532-23553","source":"Crossref","is-referenced-by-count":10,"title":["Discovery of\nNP3-742: A Structurally Diverse NLRP3\nInhibitor Identified through an Unusual Phenol Replacement"],"prefix":"10.1021","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6564-1448","authenticated-orcid":true,"given":"Juraj","family":"Velcicky","sequence":"first","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8711-2782","authenticated-orcid":true,"given":"Jean-Baptiste","family":"Langlois","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wright","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Janser","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-2829","authenticated-orcid":true,"given":"Daniela","family":"Angst","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Arnold","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Beltz","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Brenneisen","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Dubois","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4615-4091","authenticated-orcid":true,"given":"Janet","family":"Dawson","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Fischer","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Gommermann","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heizmann","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavica","family":"Ilic","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5081-6268","authenticated-orcid":true,"given":"Rainer","family":"Machauer","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Maschlej","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Monnerat","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pflieger","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinda","family":"Ristov","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Rubert","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu\u0308nther","family":"Schwalm","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Smith","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honnappa","family":"Srinivas","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Steiner","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Stojanovic","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Troxler","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Unterreiner","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vangrevelinghe","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"von Burg","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wunderlich","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-9721","authenticated-orcid":true,"given":"Christopher J.","family":"Farady","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0816-3309","authenticated-orcid":true,"given":"Angela","family":"Mackay","sequence":"additional","affiliation":[{"name":"Novartis BioMedical Research , ,","place":["Basel, Switzerland, CH-4002"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"2026073103142959800_cit1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.gendis.2023.01.009","article-title":"Fantastic\nvoyage: The journey of NLRP3 inflammasome activation","volume":"11","author":"Que","year":"2024","journal-title":"Genes Dis."},{"key":"2026073103142959800_cit2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome:\nFrom signalling mechanisms to therapeutic targets","volume":"23","author":"Vande Walle","year":"2024","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026073103142959800_cit3","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.108753","article-title":"The intricate biophysical puzzle\nof caspase-1 activation","volume":"699","author":"Makoni","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"2026073103142959800_cit4","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","article-title":"Molecular mechanisms\nof gasdermin D pore-forming activity","volume":"24","author":"Devant","year":"2023","journal-title":"Nat. Immunol."},{"key":"2026073103142959800_cit5","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1\nin the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"2026073103142959800_cit6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine\nin immunity,\ninflammation, and autoimmunity: Biological role in induction, regulation,\nand treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front. Immunol."},{"key":"2026073103142959800_cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155781","article-title":"Balance between\ninterleukin-18 and interleukin-18 binding protein in auto-inflammatory\ndiseases","volume":"150","author":"Harel","year":"2022","journal-title":"Cytokine"},{"key":"2026073103142959800_cit8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.autrev.2012.07.026","article-title":"Targeting interleukin-1\u03b2\nin CAPS (cryopyrin-associated periodic)\nsyndromes: what did we learn?","volume":"12","author":"Kone\u0301-Paut","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"2026073103142959800_cit9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus:\nThe molecular pathophysiology of autoinflammatory disease","volume":"27","author":"Masters","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"2026073103142959800_cit10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41584-022-00797-1","article-title":"IL-1 and autoinflammatory\ndisease: Biology, pathogenesis\nand therapeutic targeting","volume":"18","author":"Broderick","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"2026073103142959800_cit11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00702-017-1732-9","article-title":"The IL-1\u03b2\nphenomena in neuroinflammatory diseases","volume":"125","author":"Mendiola","year":"2018","journal-title":"J.\nNeural Transm."},{"key":"2026073103142959800_cit12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab\nfor atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"2026073103142959800_cit13","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect\nof interleukin-1\u03b2 inhibition with canakinumab on incident lung\ncancer in patients with atherosclerosis: exploratory results from\na randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"2026073103142959800_cit14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.7326\/M20-0527","article-title":"Effects of interleukin-1\u03b2\ninhibition\non incident hip and knee replacement: Exploratory analyses from a\nrandomized, double-blind, placebo-controlled trial","volume":"173","author":"Schieker","year":"2020","journal-title":"Ann. Int. Med."},{"key":"2026073103142959800_cit15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.7326\/M19-2945","article-title":"Effects of interleukin-1\u03b2 inhibition\non incident anemia: Exploratory analyses from a randomized trial","volume":"172","author":"Vallurupalli","year":"2020","journal-title":"Ann. Int. Med."},{"key":"2026073103142959800_cit16","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1016\/S0021-9258(18)83546-3","article-title":"A pre-aspartate-specific\nprotease from human leukocytes that cleaves pro-interleukin-1 \u03b2","volume":"264","author":"Black","year":"1989","journal-title":"J. Biol. Chem."},{"key":"2026073103142959800_cit17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115861","article-title":"Interleukin-1\u03b2\nconverting enzyme\n(ICE): A comprehensive review on discovery and development of caspase-1\ninhibitors","volume":"261","author":"Modi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"2026073103142959800_cit18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3\ninflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat.\nRev. Drug Discovery"},{"key":"2026073103142959800_cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115750","article-title":"Medicinal\nchemistry strategies targeting NLRP3 inflammasome pathway: A recent\nupdate from 2019 to mid-2023","volume":"260","author":"Duan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"2026073103142959800_cit20","doi-asserted-by":"publisher","first-page":"16567","DOI":"10.1074\/jbc.M211596200","article-title":"Glutathione s-transferase omega 1\u20131\nis a target of cytokine release inhibitory drugs and may be responsible\nfor their effect on interleukin-1beta posttranslational processing","volume":"278","author":"Laliberte","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2026073103142959800_cit21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets\nthe NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"2026073103142959800_cit22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule\ninhibitor of the NLRP3 inflammasome\nfor the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"2026073103142959800_cit23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167309","article-title":"Crystal structure of NLRP3 NACHT domain with an inhibitor\ndefines mechanism of inflammasome inhibition","volume":"433","author":"Dekker","year":"2021","journal-title":"J. Mol. Biol."},{"key":"2026073103142959800_cit24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome\nin response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"2026073103142959800_cit25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated\nuric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"2026073103142959800_cit26","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated\nby cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"2026073103142959800_cit27","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3\ninflammasome is involved in the innate immune\nresponse to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"2026073103142959800_cit28","doi-asserted-by":"publisher","first-page":"20776","DOI":"10.1021\/acs.jmedchem.4c02846","article-title":"Brain penetrant\nNLRP3 inhibitors: The discovery of a Panacea?","volume":"67","author":"Harrison","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2024.104810","article-title":"The research progression\nof direct NLRP3 inhibitors to treat inflammatory disorders","volume":"397\u2013398","author":"Chen","year":"2024","journal-title":"Cell. Immunol."},{"key":"2026073103142959800_cit30","doi-asserted-by":"publisher","first-page":"14447","DOI":"10.1021\/acs.jmedchem.3c01370","article-title":"Recent progress and prospects of small molecules for\nNLRP3 inflammasome inhibition","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1422249","article-title":"Screening\nNLRP3 drug candidates in clinical development: Lessons from existing\nand emerging technologies","volume":"15","author":"Tengesdal","year":"2024","journal-title":"Front. Immunol."},{"key":"2026073103142959800_cit32","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13789","article-title":"First-in-human safety, tolerability,\nand pharmacokinetic results\nof DFV890, an oral low-molecular-weight NLRP3 inhibitor","volume":"17","author":"Gatlik","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"2026073103142959800_cit33","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1021\/acs.jmedchem.4c02759","article-title":"Discovery of DFV890, a potent sulfonimidamide-containing\nNLRP3 inflammasome inhibitor","volume":"68","author":"Shen","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit34","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1471","article-title":"A randomized,\ndouble-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics\nand pharmacodynamics of the NLRP3 inhibitor Selnoflast in patients\nwith moderate to severe active ulcerative colitis","volume":"13","author":"Klughammer","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"2026073103142959800_cit35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpdd.1162","article-title":"Safety, tolerability,\npharmacokinetics,\nand pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1:\nFirst-in-Human Phase 1 studies (single ascending dose and multiple\nascending dose)","volume":"12","author":"Parmar","year":"2023","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"2026073103142959800_cit36","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","article-title":"Discovery of clinical candidate NT-0796,\na brain-penetrant and highly potent NLRP3 inflammasome inhibitor for\nneuroinflammatory disorders","volume":"66","author":"Harrison","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit37","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1021\/acs.jmedchem.3c02098","article-title":"Discovery of potent, orally bioavailable,\ntricyclic NLRP3 inhibitors","volume":"67","author":"Velcicky","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit38","doi-asserted-by":"publisher","first-page":"20780","DOI":"10.1021\/acs.jmedchem.4c02350","article-title":"Discovery\nof NP3\u2013253, a potent brain penetrant inhibitor of the NLRP3\ninflammasome","volume":"67","author":"Mackay","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit39","doi-asserted-by":"publisher","first-page":"15711","DOI":"10.1021\/acs.jmedchem.4c01341","article-title":"Discovery of potent, specific, and orally available\nNLRP3 inflammasome\ninhibitors based on pyridazine scaffolds for the treatment of septic\nshock and peritonitis","volume":"67","author":"Fu","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit40","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1021\/acs.jmedchem.4c03108","article-title":"Discovery\nof potent and brain-penetrant bicyclic NLRP3 inhibitors with peripheral\nand central in vivo activity","volume":"68","author":"Mammoliti","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2024.118042","article-title":"Discovery of 2-(6-{[(1R,2R)-2-hydroxycyclohexyl]amino}-4,5-dimethylpyridazin-3-yl)-5-(trifluoromethyl)phenol\n(ASP0965): A potent, orally active and brain-penetrable NLRP3 inflammasome\ninhibitor with a novel scaffold for the treatment of \u03b1-synucleinopathy","volume":"118","author":"Inagaki","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"2026073103142959800_cit42","doi-asserted-by":"publisher","first-page":"14195","DOI":"10.1021\/acs.jmedchem.5c00781","article-title":"Discovery of AZD4144,\na selective and potent NLRP3 inhibitor for the treatment of inflammatory\ndiseases","volume":"68","author":"Johansson","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit43","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400700","article-title":"Phenol (bio)isosteres\nin drug design\nand development","volume":"358","author":"Dunker","year":"2025","journal-title":"Arch. Pharm."},{"key":"2026073103142959800_cit44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121353119","article-title":"Structural\nbasis for\nthe oligomerization-mediated regulation of NLRP3 inflammasome activation","volume":"119","author":"Ohto","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026073103142959800_cit45","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","article-title":"Cryo-EM structures of the active\nNLRP3 inflammasome disc","volume":"613","author":"Xiao","year":"2023","journal-title":"Nature"},{"key":"2026073103142959800_cit46","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s41467-024-45396-8","article-title":"Structural basis for\nthe oligomerization-facilitated NLRP3 activation","volume":"15","author":"Yu","year":"2024","journal-title":"Nat. Commun."},{"key":"2026073103142959800_cit47","doi-asserted-by":"publisher","first-page":"7044","DOI":"10.1021\/acs.jmedchem.2c00223","article-title":"Phenols\nin pharmaceuticals: Analysis\nof a recurring motif","volume":"65","author":"Scott","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit48","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1021\/acs.jmedchem.8b00077","article-title":"Lipophilic\nefficiency as an important\nmetric in drug design","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10822-020-00337-7","article-title":"ReSCoSS: a\nflexible quantum chemistry\nworkflow identifying relevant solution conformers of drug-like molecules","volume":"35","author":"Udvarhelyi","year":"2021","journal-title":"J. Comput.-Aided Mol. Des."},{"key":"2026073103142959800_cit50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jfluchem.2013.02.023","article-title":"On the polarity\nof partially fluorinated methyl groups","volume":"152","author":"Huchet","year":"2013","journal-title":"J. Fluorine\nChem."},{"key":"2026073103142959800_cit51","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.3762\/bjoc.16.200","article-title":"Conformational preferences of fluorine-containing\nagrochemicals and their implications for lipophilicity prediction","volume":"16","author":"Silva","year":"2020","journal-title":"Beilstein J. Org. Chem."},{"key":"2026073103142959800_cit52","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1039\/p29720001905","article-title":"A dipole moment study\nof the electrical effect of the trifluoromethyl group","author":"Hepworth","year":"1972","journal-title":"J. Chem. Soc., Perkin Trans. 2"},{"key":"2026073103142959800_cit53","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/jmsp.1996.0071","article-title":"The microwave\nspectrum and dipole\nmoment of monofluorobenzene","volume":"176","author":"Onda","year":"1996","journal-title":"J. Mol. Spectrosc."},{"key":"2026073103142959800_cit54","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1002\/cphc.201600420","article-title":"On the additivity\nof molecular fragment dipole moments of 5-substituted indole derivatives","volume":"17","author":"Wilke","year":"2016","journal-title":"ChemPhysChem"},{"key":"2026073103142959800_cit55","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1021\/cr00002a004","article-title":"A survey of Hammett substituent constants and resonance\nand field parameters","volume":"91","author":"Hansch","year":"1991","journal-title":"Chem. Rev."},{"key":"2026073103142959800_cit56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112290","article-title":"hERG toxicity assessment:\nUseful guidelines for drug\ndesign","volume":"195","author":"Garrido","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"2026073103142959800_cit57","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1021\/jm060379l","article-title":"Medicinal chemistry\nof hERG optimizations: Highlights and hang-ups","volume":"49","author":"Jamieson","year":"2006","journal-title":"J. Med. Chem."},{"key":"2026073103142959800_cit58","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1039\/D4MD00275J","article-title":"Lead optimization of OXS007417: in vivo PK profile and hERG liability modulation to optimize a small molecule\ndifferentiation agent for the potential treatment of acute myeloid\nleukaemia","volume":"15","author":"Cogswell","year":"2024","journal-title":"RSC Med. Chem."},{"key":"2026073103142959800_cit59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115621","article-title":"Azaindole\nderivatives as potential kinase inhibitors and their SARs elucidation","volume":"258","author":"Fang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"2026073103142959800_cit60","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1002\/anie.200802482","article-title":"Palladium-catalyzed oxidative cyclization of N-aryl\nenamines: From anilines to indoles","volume":"47","author":"Wu\u0308rtz","year":"2008","journal-title":"Angew. Chem.,\nInt. Ed. Engl."},{"key":"2026073103142959800_cit61","doi-asserted-by":"publisher","first-page":"9098","DOI":"10.1021\/ja3030824","article-title":"Palladium-catalyzed aerobic oxidative cyclization of\nN-aryl imines: Indole synthesis from anilines and ketones","volume":"134","author":"Wei","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"2026073103142959800_cit62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/9781118695692.ch9","article-title":"Wittig\u2013Madelung\nIndole Synthesis","volume-title":"Indole Ring Synthesis:\nFrom Natural Products to Drug Discovery","author":"Gribble","year":"2016"},{"key":"2026073103142959800_cit63","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1039\/p19960001261","article-title":"Novel indole-ring\nformation by thermolysis of 2-(N-acylamino)-benzylphosphonium salts.\nEffective synthesis of 2-trifluoromethylindoles","volume":"1","author":"Miyashita","year":"1996","journal-title":"J. Chem. Soc., Perkin Trans."},{"key":"2026073103142959800_cit64","doi-asserted-by":"publisher","first-page":"11068","DOI":"10.1002\/anie.202010631","article-title":"The 2-pyridyl\nproblem: Challenging nucleophiles in cross-coupling arylations","volume":"60","author":"Cook","year":"2021","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"2026073103142959800_cit65","unstructured":"Bouche, L. A.; Guba, W.; Jaeschke, G.; Marx, A.; Mesch, S. K.; Patiny-Adam, A.; Schnider, C.; Steiner, S.; Tosstorff, A. M.\n          Novel compounds. WO2023\/232917, 2023."},{"key":"2026073103142959800_cit66","unstructured":"Nagano, T.; Okabe, T.; Kojima, H.; Saito, N.; Nakano, H.; Abe, M.; Tanaka, A.; Honma, T.; Yokoyama, S.; Tsuganezawa, K.; Yuki, H.\n          Anticancer agent. EP2565192A1, 2013."},{"key":"2026073103142959800_cit67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1107\/S0907444909047374","article-title":"Integration,\nscaling, space-group assignment and post-refinement","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"2026073103142959800_cit68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data processing and\nanalysis with the autoPROC toolbox","volume":"67","author":"Vonrhein","year":"2011","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"2026073103142959800_cit69","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development\nof Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr.,\nSect. D: Biol. Crystallogr."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c02412","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/21\/23532\/66299740\/acs.jmedchem.5c02412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/21\/23532\/66299740\/acs.jmedchem.5c02412.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:14:32Z","timestamp":1785482072000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/21\/23532\/5235038\/Discovery-of-NP3-742-A-Structurally-Diverse-NLRP3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":69,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2025,11,13]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02412","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02412.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02412.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02412.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02412.s004","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]}}}